[HTML][HTML] Immune responses to injury and their links to eye disease

MANN Stepp, ASUE Menko - Translational Research, 2021 - Elsevier
The eye is regarded as an immune privileged site. Since the presence of a vasculature
would impair vision, the vasculature of the eye is located outside of the central light path. As …

Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma

Y Miao, GL Zhao, S Cheng, Z Wang, XL Yang - Progress in retinal and eye …, 2023 - Elsevier
Elevation of intraocular pressure (IOP) is a major risk factor for neurodegeneration in
glaucoma. Glial cells, which play an important role in normal functioning of retinal neurons …

Crosstalk between dysfunctional mitochondria and inflammation in glaucomatous neurodegeneration

AH Jassim, DM Inman, CH Mitchell - Frontiers in pharmacology, 2021 - frontiersin.org
Mitochondrial dysfunction and excessive inflammatory responses are both sufficient to
induce pathology in age-dependent neurodegenerations. However, emerging evidence …

Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies

NA Sharif - Frontiers in pharmacology, 2021 - frontiersin.org
Damage to the optic nerve and the death of associated retinal ganglion cells (RGCs) by
elevated intraocular pressure (IOP), also known as glaucoma, is responsible for visual …

Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma

M Harun-Or-Rashid, DM Inman - Journal of neuroinflammation, 2018 - Springer
Background Glaucoma is a chronic degenerative disease for which inflammation is
considered to play a pivotal role in the pathogenesis and progression. In this study, we …

Glaucoma: a degenerative optic neuropathy related to neuroinflammation?

S Mélik Parsadaniantz, A Réaux-le Goazigo… - Cells, 2020 - mdpi.com
Glaucoma is one of the leading causes of irreversible blindness in the world and remains a
major public health problem. To date, incomplete knowledge of this disease's …

Retinal ganglion cell death in glaucoma: Exploring the role of neuroinflammation

R Russo, GP Varano, A Adornetto, C Nucci… - European journal of …, 2016 - Elsevier
In clinical glaucoma, as well as in experimental models, the loss of retinal ganglion cells
occurs by apoptosis. This final event is preceded by inflammatory responses involving the …

Targeting the NLRP3 inflammasome in glaucoma

S Coyle, MN Khan, M Chemaly, B Callaghan, C Doyle… - Biomolecules, 2021 - mdpi.com
Glaucoma is a group of optic neuropathies characterised by the degeneration of retinal
ganglion cells, resulting in damage to the optic nerve head (ONH) and loss of vision in one …

FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucoma

NA Sharif, N Odani-Kawabata, F Lu… - Experimental Eye …, 2023 - Elsevier
Prostaglandin (PG) receptors represent important druggable targets due to the many diverse
actions of PGs in the body. From an ocular perspective, the discovery, development, and …

The role of axonal transport in glaucoma

MS Dias, X Luo, VT Ribas, H Petrs-Silva… - International Journal of …, 2022 - mdpi.com
Glaucoma is a neurodegenerative disease that affects the retinal ganglion cells (RGCs) and
leads to progressive vision loss. The first pathological signs can be seen at the optic nerve …